Tulåh Scientific Wellness in Kozhikode, Kerala, has partnered with US-based medical second-opinion platform Apex Opinion. The collaboration will give Indian sufferers entry to unbiased assessments from US board-certified specialists with out travelling abroad. The service is anticipated to launch in November 2026, topic to operational readiness.
The 2 events signed a Memorandum of Understanding in Boston on 30 October 2026. Faizal E. Kottikollon, Founder and Chairman of KEF Holdings and Tulåh Scientific Wellness, signed on behalf of Tulåh. Saurabh Sanon, Founder and CEO of Krivox Inc., which operates Apex Opinion, represented the US platform.
The partnership helps Tulåh’s imaginative and prescient of mixing trendy medication with conventional therapeutic practices. It would initially cowl complicated medical situations throughout a number of specialties, together with cardiology, oncology and neurology.
Sufferers will be capable to submit their medical data for evaluation by US specialists. They’ll count on to obtain professional opinions inside seven enterprise days. The service can also provide video consultations with specialists.
“Our collaboration with Apex Opinion is one other step in the direction of making international medical experience accessible to folks in India,” stated Kottikollon.
Sanon added: “We hope to make professional US medical opinions extra accessible to sufferers in India, while making certain that their ongoing care stays with their very own treating physicians.”
The partnership goals to provide sufferers better confidence of their diagnoses and therapy choices. It would additionally permit them to entry worldwide medical experience whereas persevering with their care with native physicians.
This story was chosen and revealed by a human editor, with content material tailored from authentic press materials utilizing AI instruments. Spot an error? Report it right here.
